Navigation Links
Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
Date:4/24/2012

NANJING, China, April 24, 2012 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2012 on Wednesday, May 9, 2012, before the market opens in the United States. Simcere's management will host an earnings conference call on the same day at 8 a.m. ET (Wednesday, May 9, at 8 p.m. Beijing/Hong Kong time).

To access the conference call, please dial:International toll:+65.6723.9381United States toll-free:+1.866.519.4004United States toll:+1.718.354.1231China Domestic toll:800.819.0121 China Domestic mobile toll:400.620.8038 Hong Kong toll:+852.2475.0994Please ask to be connected to Q1 2012 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 73500159.Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at www.simcere.com.

Following the earnings conference call, an archive of the call will be available by dialing:United States toll-free:+1.866.214.5335United States toll:+1.718.354.1232The passcode for replay participants is 73500159. The telephone replay also will be archived on the "Investor Relations" section of the company's website for seven days following the earnings announcement.

About Simcere Pharmaceutical GroupSimcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com.Investor and Media Contacts: Email: ir@simcere.com In Nanjing:In the United States:Yehong ZhangCindy ZhengPresidentBrunswick GroupSimcere Pharmaceutical GroupTel: 1-212-333-3810Tel: 86-25-8556-6666 ext. 8811In Beijing:In Hong Kong:Yue YuJoseph Lo Chi-LunBrunswick GroupBrunswick GroupTel: 86-10-5960-8Tel: 852-3512-5000   

 

 


'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results
2. Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound
3. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2011 Results
4. Simcere Pharmaceutical Group to Announce Third Quarter 2011 Financial Results on Monday, November 14, 2011
5. Simceres Iremod Receives SFDA New Drug Approval
6. Simceres Branded Generic Formulation Biqi Passes EU-GMP Inspection
7. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2011 Results
8. Simcere Pharmaceutical Group to Announce Second Quarter 2011 Financial Results on Tuesday, August 9, 2011
9. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
10. Simcere Pharmaceutical Group Filed 2010 Annual Report on Form 20-F
11. Simcere Announces Recent Progress of Qiangkes Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2019)... ... November 08, 2019 , ... WHAT:, Lillstreet Art Center and the Center for ... to learn how to create clay candy creatures using pinch pot techniques. Attendees will ... their pots in a sensory-friendly environment. , “We have been working on this ...
(Date:11/7/2019)... ... November 07, 2019 , ... Today, Salimetrics' SalivaLab released a ... menu in an effort to support researchers interested in expanding their research by ... help facilitate a growing need for new markers that can further define complex human ...
(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... Dutch Bros ... of Breast Cancer Awareness Month. $10 from each “Be Aware” mug sold in October ... so grateful for the opportunity to help support these amazing organizations,” said Travis Boersma, ...
Breaking Medicine Technology:
(Date:11/11/2019)... ... November 11, 2019 , ... ... shipment of two (2) Gruenberg Depyrogenation Sterilizers to the Pharmaceutical Industry. ... have maximum temperature ratings of 280°C with work chamber dimensions of 36” W ...
(Date:11/11/2019)... , ... November 11, 2019 , ... ... care, accessible primary care and occupational medicine, is expanding its long-term partnership with ... target and engage franchise candidates. With more than 200 locations across the country, ...
(Date:11/11/2019)... ... , ... Dr. John V. Prunskis, co-founder and co-Medical Director of the Illinois ... Best Practices Task Force (Pain Task Force) met last Monday with Joe Grogan, the ... HHS Pain Task Force’s final report that was submitted to Congress in May of ...
(Date:11/9/2019)... ... November 08, 2019 , ... The Women’s Dermatologic Society ... to health concerns. The WDS Board of Directors appointed Molly Hinshaw, MD to fill ... the current March 2019-March 2020 term and will be presented to the membership as ...
(Date:11/9/2019)... ... November 08, 2019 , ... Mount Sinai Medical-Legal Partnership (MSMLP), an ... initiatives that provide free special education law and advocacy assistance to families and patients ... that also honored the work of contributions of Blaine (“Fin”) Fogg, who was a ...
Breaking Medicine News(10 mins):